CMVpp65 epitope specificity of peripheral blood virus-specific T-cell lines
| Peripheral blood CTL ID . | HLA typing . | CMVpp65 epitope(s) . |
|---|---|---|
| PB1 | A1;24/B51;57 | QYDPVAALF 369-379: FTSQYRIQGKL 113-121:VYALPLKML |
| PB2 | A1;80/B7;53 | TPRVTGGGAMRPHERNGFTVL |
| PB3 | A2/B8;49 | NLVPMVATV |
| PB4 | A2402,3201/B1302,3501 | QYDPVAALF |
| PB5 | A2;68/B35;40 | NLVPMVATV |
| PB6 | A1;2/B8;15 | NLVPMVATV |
| PB7 | A2,66/B27(w6),52(w6) | NLVPMVATV |
| PB8 | A2,3/B7,44 | NLVPMVATVTPRVTGGGAMRPHERNGFTVL |
| PB9 | A2/B40(61);46 | NLVPMVATV |
| PB10 | A2/B35;39 | NLVPMVATV |
| PB11 | A2;3/B1501;5301 | NLVPMVATV |
| Peripheral blood CTL ID . | HLA typing . | CMVpp65 epitope(s) . |
|---|---|---|
| PB1 | A1;24/B51;57 | QYDPVAALF 369-379: FTSQYRIQGKL 113-121:VYALPLKML |
| PB2 | A1;80/B7;53 | TPRVTGGGAMRPHERNGFTVL |
| PB3 | A2/B8;49 | NLVPMVATV |
| PB4 | A2402,3201/B1302,3501 | QYDPVAALF |
| PB5 | A2;68/B35;40 | NLVPMVATV |
| PB6 | A1;2/B8;15 | NLVPMVATV |
| PB7 | A2,66/B27(w6),52(w6) | NLVPMVATV |
| PB8 | A2,3/B7,44 | NLVPMVATVTPRVTGGGAMRPHERNGFTVL |
| PB9 | A2/B40(61);46 | NLVPMVATV |
| PB10 | A2/B35;39 | NLVPMVATV |
| PB11 | A2;3/B1501;5301 | NLVPMVATV |